Bigd..you've done a fine job here keeping in touch with the company and I remember you've mentioned a buy-back a few times in the past. This is very important for shareholders as a buy-back will push this pps to the stratosphere.
I would like to see XKEM selling at $10, $25, $50 range just like most pharmaceutical companies that are generating $1+ billion in revenues.
Now may not be the time but this ought to be hammered into Dr. Pandey so he knows to do it when the time is right.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.